SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-005853
Filing Date
2023-03-01
Accepted
2023-03-01 16:31:10
Documents
88
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K gthx-20221231.htm   iXBRL 10-K 2361458
2 EX-10.22 exhibit1022.htm EX-10.22 34290
3 EX-10.25 exhibit1025.htm EX-10.25 48284
4 EX-23.1 exhibit231.htm EX-23.1 2810
5 EX-31.1 exhibit311.htm EX-31.1 10802
6 EX-31.2 exhibit312.htm EX-31.2 10791
7 EX-32.1 exhibit321.htm EX-32.1 4339
8 EX-32.2 exhibit322.htm EX-32.2 4361
14 gthx-20221231_g1.jpg GRAPHIC 8623
15 gthx-20221231_g2.jpg GRAPHIC 129203
  Complete submission text file 0001628280-23-005853.txt   9629656

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gthx-20221231.xsd EX-101.SCH 59789
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gthx-20221231_cal.xml EX-101.CAL 79895
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gthx-20221231_def.xml EX-101.DEF 253758
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gthx-20221231_lab.xml EX-101.LAB 713950
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gthx-20221231_pre.xml EX-101.PRE 461119
82 EXTRACTED XBRL INSTANCE DOCUMENT gthx-20221231_htm.xml XML 1425250
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38096 | Film No.: 23694084
SIC: 2834 Pharmaceutical Preparations